This is a mechanism module, not a specific disease — do NOT create an "NMDA Receptor Hypofunction" Disease entry. Disorder entries reference individual nodes via conforms_to (e.g. "nmda_receptor_hypofunction#Reduced NMDA Receptor-Mediated Calcium Influx"). The module was factored out of the AOP-Wiki mapping work in dismech#8309/#9976: AOP 12 (WPHA/WNT endorsed, "Chronic binding of antagonist to NMDARs during brain development leads to neurodegeneration with impairment in learning and memory in aging") has three Key Events — KE201 (binding of antagonist, NMDA receptors), KE195 (inhibition, NMDARs) and KE52 (decreased calcium influx) — plus KE381 (reduced levels of BDNF) that no dismech module could accept, because glutamate_excitotoxicity is built end to end on the opposite sign. The node names here are deliberately direction-explicit for the same reason. Conformance may be partial: the developmental toxicant conformers (lead, ethanol) carry the whole chain, whereas anti-NMDAR encephalitis reaches the same receptor-hypofunction and calcium nodes through autoantibody-mediated receptor loss in a mature brain and therefore conforms at the upstream nodes without the developmental BDNF arm. Schizophrenia is deliberately NOT wired as a conformer: its NMDA-hypofunction model is specific to parvalbumin interneurons and proceeds through cortical disinhibition, which is a different downstream chain. The generic cell type is glutamatergic neuron (CL:0000679); conforming entries substitute the relevant population (hippocampal pyramidal neuron, cortical neuron). Note the molecular chain below the calcium node is evidenced almost entirely in cultured rodent neurons and in vivo rodent models; the human evidence is epidemiological, which is recorded as a HUMAN_MODEL_MISMATCH discussion rather than smoothed over.
Does the NMDA-receptor-to-calcium-to-BDNF chain characterized in cultured embryonic rat hippocampal neurons and in neonatal rodents operate in the developing human brain, or is the human evidence compatible with a different mechanism linking developmental exposure to cognitive deficit?
HUMAN MODEL MISMATCH
nmdar_hypofunction_bdnf_human_translation
Attached to:
Reduced BDNF Expression and Secretion
Learning and Memory Impairment
The two ends of this module are evidenced in different systems and the middle is not bridged in humans. The outcome node rests on human epidemiology — a pooled analysis of seven longitudinal cohorts showing an inverse blood-lead to IQ relationship with no apparent threshold — while every step from receptor block through calcium entry to BDNF-TrkB signalling and vesicular release is measured in cultured rat hippocampal neurons or in neonatal rodents. The rodent work is strong on its own terms, including a rescue experiment in which exogenous BDNF restores the presynaptic deficit, but no human study measures BDNF or NMDA-receptor function in exposed children, and lead has well-documented parallel neuronal actions (calcium mimicry in second messenger signalling, protein kinase C dysregulation, oxidative stress) that could produce the same cognitive endpoint. The developmental window is also species-scaled: the synaptogenesis period that confers vulnerability spans days in the rat and from roughly the sixth month of gestation to several years after birth in humans, so exposure timing does not translate directly.
Proposed experiments:
Human iPSC-derived neuron reconstruction of the receptor-calcium-BDNF chain
BDNF biomarker dose-response in an exposed paediatric cohort
NMDA Receptor Antagonism or Receptor Loss
trigger
The shared initiating lesion is a reduction in the number or availability of functional NMDA receptors at glutamatergic synapses. Two routes converge here. In the toxicant and pharmacological route, a ligand blocks the receptor directly: Pb2+ inhibits the NMDA-receptor ion-channel complex selectively over AMPA and kainate receptors, ethanol antagonizes NMDA receptors during the synaptogenesis window, and dissociative anaesthetics act as open-channel blockers. In the autoimmune route, IgG against the GluN1 subunit caps and internalizes surface receptors without blocking the channel pore. Conforming entries substitute their own route; what the module asserts is only that the functional receptor pool is reduced.
Downstream
-
NMDA Receptor Hypofunction
Fewer available or conductive receptors reduce NMDA-receptor-mediated current, whether the receptors are blocked in place or removed from the surface.
Show evidence (4 references)
"Pb2+ (2.5-50 microM) selectively inhibited N-methyl-D-aspartate (NMDA)-induced whole-cell and single-channel currents in a concentration-dependent but voltage-independent manner, without significantly altering currents induced by either quisqualate or kainate."
Establishes the toxicant route to the trigger, and its selectivity for the NMDA receptor over the other ionotropic glutamate receptors, which is what makes this module narrower than a general glutamatergic-signalling module.
"The amplitude of the NMDA-activated current was reduced 61 percent by 50 mM EtOH; in contrast, this concentration of EtOH reduced the amplitude of current activated by the glutamate receptor agonists kainate and quisqualate by only 18 and 15 percent, respectively."
A second, chemically unrelated antagonist reaching the same trigger with the same receptor selectivity as lead, which is what makes the node module-shaped rather than a detail of lead poisoning. Ethanol also potentiates GABA(A) receptors in parallel, so a conforming fetal alcohol node is partial.
"Vulnerability coincides with the period of synaptogenesis, which in humans extends from the sixth month of gestation to several years after birth."
Sets the developmental window over which this trigger is damaging, which is why the module is scoped to developmental exposure for the toxicant conformers. The window is inferred from rat forebrain exposure and mapped onto human synaptogenesis by the authors.
+ 1 more reference
NMDA Receptor Hypofunction
amplifier
Reduced NMDA-receptor channel activity at glutamatergic synapses — the functional state the two upstream routes converge on. Measured as decreased NMDA-evoked whole-cell and single-channel current, reduced channel opening frequency, or decreased NMDAR-mediated miniature EPSC amplitude. AMPA- and kainate-receptor-mediated transmission is characteristically spared, which distinguishes this node from a global loss of excitatory transmission.
Downstream
-
Reduced NMDA Receptor-Mediated Calcium Influx
The NMDA receptor is the principal activity-gated calcium-permeable channel at the excitatory synapse, so reduced channel activity translates directly into reduced calcium entry.
Show evidence (2 references)
"The frequency of NMDA-induced channel activation was decreased by Pb2+."
A single-channel measurement of the hypofunction state itself, independent of which ligand produced it.
"Blockade of N-methyl-D-aspartate (NMDA) glutamate receptors for only a few hours during late fetal or early neonatal life triggered widespread apoptotic neurodegeneration in the developing rat brain, suggesting that the excitatory neurotransmitter glutamate, acting at NMDA receptors, controls..."
Establishes that NMDA-receptor hypofunction is by itself sufficient to injure the developing brain, and that the developmental window is short — the reason this module is scoped to the suppressed direction rather than treated as a mild form of normal signalling.
Reduced BDNF Expression and Secretion
effector
Loss of the calcium-dependent transcriptional drive lowers BDNF gene and protein expression and reduces the extracellular mature BDNF available at the synapse. Transport and processing are affected alongside transcription, and TrkB receptor levels and autophosphorylation fall in parallel, so the deficit is in BDNF-TrkB signalling as a whole rather than in ligand abundance alone.
Downstream
-
Impaired Activity-Dependent Synaptic Plasticity
BDNF-TrkB signalling is the principal trophic mediator of activity-dependent synaptic strengthening, so its loss degrades plasticity.
Show evidence (2 references)
"We show that Pb(2+) exposure decreases BDNF gene and protein expression, and it may also alter the transport of BDNF vesicles to sites of release by altering Huntingtin phosphorylation and protein levels."
Direct measurement of the reduced-BDNF node in hippocampal neurons exposed during synaptogenesis, covering both expression and delivery.
"We show that NMDAR inhibition by aminophosphonovaleric acid mimics the presynaptic effects of Pb(2+) exposure."
A pharmacological NMDA-receptor antagonist reproduces the deficit, which attributes it to receptor hypofunction itself rather than to any other action of lead — the key control for the upstream half of this module.
Impaired Activity-Dependent Synaptic Plasticity
effector
Degraded activity-dependent modification of synaptic strength and of presynaptic vesicular release, evidenced as impaired long-term potentiation, loss of vesicular-release proteins, and reduced numbers of fast-releasing sites. In the developmental conformers this coincides with the synaptogenesis window, so the deficit is built into the circuit rather than imposed on a mature one.
Downstream
-
Learning and Memory Impairment
Hippocampal and cortical plasticity is the substrate of declarative learning, so a plasticity deficit acquired during development presents as a cognitive deficit.
Show evidence (2 references)
"A prevailing hypothesis is that activity-dependent synaptic modulation is mediated by neurotrophins."
States the BDNF-to-plasticity dependence this node rests on, and states it as a prevailing hypothesis rather than a settled result.
"Analysis of vesicular release using FM 1-43 dye confirmed that Pb(2+) exposure impaired vesicular release and reduced the number of fast-releasing sites."
A functional measurement of degraded synaptic transmission after exposure during the synaptogenesis window.
Learning and Memory Impairment
consequence
The organism-level outcome: impaired learning and memory. In the developmental toxicant conformers this appears as a dose-dependent decrement in measured intellectual function in exposed children, with no identified threshold; in the autoimmune conformer it appears as the anterograde amnesia and behavioural disturbance of encephalitis, and is reversible with receptor recovery.
Show evidence (2 references)
"After adjustment for covariates, we found an inverse relationship between blood lead concentration and IQ score."
The human anchor for this node — a pooled analysis of seven longitudinal cohorts. Note this establishes the exposure-to-outcome association in humans, not the molecular chain above it.
"The loss of this subtype of glutamate receptors eliminates NMDAR-mediated synaptic function, resulting in the learning, memory, and other behavioral deficits observed in patients with anti-NMDAR encephalitis."
Attributes the same cognitive outcome to receptor loss in a non-toxicant, non-developmental setting, which is what makes the outcome node conserved rather than a feature of lead exposure.